In conclusion, treatment of latent tuberculosis infection is a critical component of tuberculosis control, aimed at preventing the progression to active disease. Multiple treatment regimens are available, and the choice of regimen should be individualized based on patient characteristics, potential drug interactions, and risk of progression to active disease. Monitoring for adverse effects and ensuring treatment adherence are key aspects of LTBI management.